DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
170 hedge funds and large institutions have $1.59B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 64 increasing their positions, 53 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
+26
Holders Change %
+18.06%
% of All Funds
3.49%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
36
Increased
64
Reduced
53
Closed
9
Calls
$4.15M
Puts
$2.03M
Net Calls
+$2.12M
Net Calls Change
+$2.97M
Top Buyers
| 1 |
1
State Street
Boston,
Massachusetts
|
$72.8M |
| 2 |
2
BlackRock
New York
|
$151M |
| 3 |
PA
3
Perceptive Advisors
New York
|
$20.3M |
| 4 |
4
Loomis, Sayles & Company
Boston,
Massachusetts
|
$18.4M |
| 5 |
5
Wellington Management Group
Boston,
Massachusetts
|
$110M |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$24.9M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$34.3M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$0 |
| 4 |
4
Goldman Sachs
New York
|
$13.3M |
| 5 |
EC
5
EcoR1 Capital
San Francisco,
California
|
$69.1M |
